Meanwhile, in a study including patients with stage I–IIIA NSCLC (n = 30), a value of ≥3 for PD-L1+/EMT+ CTCs in preoperative peripheral blood predicted poor RFS and OS, but RFS failed to reach statistical differences, most likely attributed to the small sample size [96]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.